Somalia PR Observer

Latest Breaking News and Updates

Diabetes

Health Maintenance

Eli Lilly and Company and Boehringer Ingelheim announce new drug application filing in the U.S. for new insulin glargine product

– New Drug Application follows submission of Marketing Authorisation Application to the European Medicines Agency INDIANAPOLIS and INGELHEIM, Germany, Dec. 20, 2013 / PRNewswire / Asianet-Pakistan – Eli Lilly and Company and Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) for LY2963016, an […]